Although recovery in inpatient volume is only expected to be modest in 2021, AmInvestment Bank said earnings are set to pick up due to potential public-private collaborations, improved margins as a result of cost-cutting measures and a focus on low capex and gestational period projects.
So far, the government has procured Pfizer, AstraZeneca and COVAX-sourced vaccines for 40% of the population. It is in negotiations with CanSino, Sinovac and the Gamaleya National Centre to provide vaccines for another 40% of the population. The vaccine supply chain is expected to benefit a number of companies including those not directly involved in healthcare.
Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più: